Preventive services are severely underutilized and contribute substantially to care gaps and preventable deaths. Three key trends promise improvement: consumerism, big data, and technology.
This study investigates the impact of state prescription drug monitoring programs on drug overdose mortality rates for all drug categories.
Patient characteristics such as psychiatric diagnosis were associated with variations in adherence, although physician characteristics were not.
The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.
An analysis of administrative claims showed increasing rates of heroin overdose among an insured population and opportunities for interventions during healthcare encounters before overdose.
The success of recommendations to improve screening often rests on the availability of efficacious therapies, coverage policies, and other factors that enable and justify screening.
This study evaluated cost and utilization attributed to members enrolled in a health care program with no pharmacy co-pay. Health care savings were identified in addition to medication adherence improvements.
Through a multi-site, multidisciplinary approach, AYA@USC addresses the unique needs of young adult cancer patients, improving outcomes and bridging the care gap in this population.
This cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.
This study examined adherence to statins and low-density lipoprotein cholesterol goal attainment in patients with coronary artery disease.
Prescription cost and pharmacy convenience were identified as the most significant drivers of out-of-plan pharmacy use.
Linking administrative claims to health-related quality of life measured in Healthy Days provides a new vision into the health of populations.
A limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.
Standardized measurement of migraine, an underdiagnosed and perhaps underrecognized condition, is necessary for health plans to understand utilization of costly diagnostic and treatment services.
As primary care physicians and leaders of Wellframe, a mobile health company working with payers and physicians groups to extend care between visits for patients with complex comorbidities, Drs Panch and Goodman discuss their experiences building a mobile application used by elderly patients to communicate with clinicians and manage chronic disease.
This study measured breast cancer screening practice patterns in relation to evidence-based guidelines and accountability metrics, and found closer alignment is needed for providing patient-centered care.
Real-world retrospective analysis of over 29,000 patients performing INR home monitoring for warfarin therapy shows excellent time in therapeutic range.